Remission of acute myeloblastic leukemia after severe pneumonia treated with high-dose methylprednisolone

International Journal of Hematology

Volumn 74, Issue 2, 2001, Pages 173-177

  Shimohakamada, Yoko ^a   Shinohara, Kenji ^a   Fukuda, Naofumi ^a  

^a Yamaguchi Pref Central Hospital   (Japan)

Author keywords

AML; Corticosteroid; Infection; Spontaneous remission

Indexed keywords

ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; FEMALE; GENETICS; HUMAN; PNEUMONIA; REMISSION;

AGED; ANTI-INFLAMMATORY AGENTS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; METHYLPREDNISOLONE; PNEUMONIA; REMISSION, SPONTANEOUS;

EID: 0035430751     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982001     Document Type: Article

References (17)

1. Martelli MP, Latagliata R, Spadea A, et al. Molecular and cytogenetic remission in a case of subtype M4E acute myelogenous leukemia with minimal monochemotherapy: high sensitivity or spontaneous remission? Eur J Haematol. 2000;65:203-206.
2. Lachant NA, Goldberg J, Nelson DA, et al. Spontaneous remission in acute myelogenous leukemia in the adult. Am J Med. 1979;67: 687-692.
3. Ifrah N, James J-M, Viguie F, et al. Spontaneous remission in adult acute leukemia. Cancer. 1985;56:1187-1190.
4. Jimemez C, Ribera JM, Abad E, et al. Increased serum tumor necrosis factor during transient remission in acute leukemia. Lancet. 1993;34:1600.
5. Paul R, Remes K, Lakkala T, et al. Spontaneous remission in acute myeloid leukaemia. Br J Haematol. 1994;86:210-212.
6. Musto P, D'Arena G, Mellillo L, et al. Spontaneous remission in acute myeloid leukaemias: a role for endogenous production of tumor necrosis factor and interleukin-2? Br J Haematol. 1994;87: 879-880.
7. Delmer A, Heron E, Marie J-P, et al. Spontaneous remission in acute myeloid leukaemia. Br J Haematol. 1994;87:880-882.
8. Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, et al. Spontaneous remission of acute myeloid leukemia after injection and blood transfusion associated with hypergammaglobulinemia. Ann Hematol. 1996;73:189-193.
9. Crabtree GR, Smith KA, Munck A. Glucocorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells. Cancer Res. 1978;38:4268-4272.
10. Kaspers GJL, Pieters R, Klumper E, et al. Glucocorticoid resistance in childhood leukemia. Leak Lymph. 1994;13:187-201.
11. Hisconmez G, Ozsoylu S, Tuncer M. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential. Lenk Res. 1991;15:537-541.
12. Hisconmez G, Erdemli E, Tekelioglu M, et al. Morphologic evidence of apoptosis in childhood acute myeloblastic leukemia treated with high-dose methylprednisolone. Lenk Lymph. 1996;22:91-96.
13. Miyoshi H, Ohki M, Nakagawa T, et al. Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation. Leuk Res. 1997;21:45-50.
14. Ozbek N, Erdemli E, Hisconmez G, et al. Effects of methylprednisolone of human myeloid leukemic cells in vitro. Am J Hematol. 1999;60:255-259.
15. Oster W, Mertelsmann R, Herrmann F. Role of colony-stimulating factors in the biology of acute myelogenous leukemia. Int J Cell Cloning. 1989;7:13-29.
16. Miyamoto T, Nakafuji K, Harada M, et al. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells harvests from patients with t(8;21) acute myelogenous leukemia. Br J Haematol. 1995;91:132-138.
17. Miyamoto T, Nakafuji K, Akashi K, et al. Persistence of multipotent progenitors expressing AML/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood. 1996;87:4789-4796.